Thomas J. Herzfeld Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-35
| Closed | -$2.73K | – | 170 |
|
|
2024
Q2 | $2.73K | Buy |
+35
| New | +$2.73K | ﹤0.01% | 182 |
|
|
2023
Q4 | – | Sell |
-166
| Closed | -$11.2K | – | 174 |
|
|
2023
Q3 | $11.2K | Hold |
166
| – | – | ﹤0.01% | 174 |
|
|
2023
Q2 | $11.9K | Sell |
166
-26
| -14% | -$1.86K | ﹤0.01% | 170 |
|
|
2023
Q1 | $13.3K | Hold |
192
| – | – | 0.01% | 143 |
|
|
2022
Q4 | $13K | Buy |
192
+57
| +42% | +$3.87K | 0.01% | 147 |
|
|
2022
Q3 | $7K | Hold |
135
| – | – | ﹤0.01% | 172 |
|
|
2022
Q2 | $9K | Hold |
135
| – | – | ﹤0.01% | 168 |
|
|
2022
Q1 | $9K | Hold |
135
| – | – | ﹤0.01% | 184 |
|
|
2021
Q4 | $8K | Hold |
135
| – | – | ﹤0.01% | 223 |
|
|
2021
Q3 | $8K | Hold |
135
| – | – | ﹤0.01% | 211 |
|
|
2021
Q2 | $8K | Buy |
135
+36
| +36% | +$2.13K | ﹤0.01% | 222 |
|
|
2021
Q1 | $5K | Hold |
99
| – | – | ﹤0.01% | 247 |
|
|
2020
Q4 | $5K | Buy |
99
+21
| +27% | +$1.06K | ﹤0.01% | 234 |
|
|
2020
Q3 | $4K | Hold |
78
| – | – | ﹤0.01% | 197 |
|
|
2020
Q2 | $4K | Buy |
+78
| New | +$4K | ﹤0.01% | 229 |
|
|
2017
Q3 | – | Sell |
-352
| Closed | -$12K | – | 290 |
|
|
2017
Q2 | $12K | Sell |
352
-233
| -40% | -$7.94K | 0.01% | 231 |
|
|
2017
Q1 | $18K | Sell |
585
-193
| -25% | -$5.94K | 0.01% | 273 |
|
|
2016
Q4 | $21K | Buy |
778
+88
| +13% | +$2.38K | 0.01% | 276 |
|
|
2016
Q3 | $23K | Sell |
690
-1,180
| -63% | -$39.3K | 0.01% | 255 |
|
|
2016
Q2 | $56K | Buy |
1,870
+111
| +6% | +$3.32K | 0.03% | 187 |
|
|
2016
Q1 | $50K | Sell |
1,759
-214
| -11% | -$6.08K | 0.03% | 199 |
|
|
2015
Q4 | $67K | Hold |
1,973
| – | – | 0.03% | 189 |
|
|
2015
Q3 | $63K | Buy |
1,973
+199
| +11% | +$6.35K | 0.03% | 180 |
|
|
2015
Q2 | $28K | Buy |
+1,774
| New | +$28K | 0.01% | 222 |
|